Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates

ABSTRACT Acute human immunodeficiency virus (HIV) infection represents a period of intense immune perturbation and activation of the host immune system. Study of the eclipse and viral expansion phases of infection is difficult in humans, but studies in nonprogressive and progressive nonhuman primate (NHP) infection models can provide significant insight into critical events occurring during this time. Cytokines, chemokines, and other soluble immune factors were measured in longitudinal samples from rhesus macaques infected with either SIVmac251 (progressive infection) or SIVmac239Δnef (attenuated/nonprogressive infection) and from African green monkeys infected with SIVsab9315BR (nonpathogenic infection). Levels of acute-phase peak viral replication were highest in SIVmac251 infection but correlated positively with viremia at 3 months postinfection in all three infection models. SIVmac251 infection was associated with stronger corresponding acute-phase cytokine/chemokine responses than the nonprogressive infections. The production of interleukin 15 (IL-15), IL-18, gamma interferon (IFN-γ), granulocyte colony-stimulating factor (G-CSF), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1β (MIP-1β), and serum amyloid A protein (SAA) during acute SIVmac251 infection, but not during SIVmac239Δnef or SIVsab9315BR infection, correlated positively with chronic viremia at 3 months postinfection. Acute-phase production of MCP-1 correlated with viremia at 3 months postinfection in both nonprogressive infections. Finally, a positive correlation between the acute-phase area under the curve (AUC) for IL-6 and soluble CD40 ligand (sCD40L) and chronic viremia was observed only for the nonprogressive infection models. While we observed dynamic acute inflammatory immune responses in both progressive and nonprogressive SIV infections, the responses in the nonprogressive infections were not only lower in magnitude but also qualitatively different biomarkers of disease progression. IMPORTANCE NHP models of HIV infection constitute a powerful tool with which to study viral pathogenesis in order to gain critical information for a better understanding of HIV infection in humans. Here we studied progressive and nonprogressive simian immunodeficiency virus (SIV) infection models in both natural and nonnatural host NHP species. Regardless of the pathogenicity of the virus infection and regardless of the NHP species studied, the magnitude of viremia, as measured by area under the curve, during the first 4 weeks of infection correlated positively with viremia in chronic infection. The magnitude of cytokine and chemokine responses during primary infection also correlated positively with both acute-phase and chronic viremia. However, the pattern and levels of specific cytokines and chemokines produced differed between nonprogressive and progressive SIV infection models. The qualitative differences in the early immune response in pathogenic and nonpathogenic infections identified here may be important determinants of the subsequent disease course.

[1]  R P Johnson,et al.  Increased rates of CD4(+) and CD8(+) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Barratt-Boyes,et al.  Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques , 2016, European journal of immunology.

[3]  D. Montefiori,et al.  Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease. , 2010, Blood.

[4]  C. Williamson,et al.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression , 2010, AIDS.

[5]  J. Lifson,et al.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.

[6]  G. Beall,et al.  Infection with HIV is associated with elevated IL-6 levels and production. , 1990, Journal of immunology.

[7]  J. Eiros,et al.  Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  M. Johnson,et al.  Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case–control analysis nested in a large clinical trial , 2015, AIDS.

[9]  J. Altman,et al.  IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses1 , 2008, The Journal of Immunology.

[10]  A. MacNeil,et al.  Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus. , 2012, Virology.

[11]  P. Fultz,et al.  Pathogenicity and comparative evolution in vivo of the transitional quasispecies SIVsmmPBj8. , 1999, Virology.

[12]  S. Frøland,et al.  Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection. , 1997, The Journal of infectious diseases.

[13]  Y. Benjamini Discovering the false discovery rate , 2010 .

[14]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[15]  V. Maino,et al.  Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.

[16]  D. Weiner,et al.  Rhesus macaques with high levels of vaccine induced IFN-gamma producing cells better control viral set-point following challenge with SIV239. , 2006, Vaccine.

[17]  P. Katsikis,et al.  The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point? , 2011, PLoS pathogens.

[18]  S. Staprans,et al.  Severe Depletion of Mucosal CD4+ T Cells in AIDS-Free Simian Immunodeficiency Virus-Infected Sooty Mangabeys1 , 2007, The Journal of Immunology.

[19]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[20]  J. Clements,et al.  The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: From mechanism to treatment , 2011, Journal of NeuroVirology.

[21]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[22]  F. Barré-Sinoussi,et al.  Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. , 2005, The Journal of clinical investigation.

[23]  David M. Rocke,et al.  Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection , 2005, Journal of Virology.

[24]  G. Silvestri,et al.  Early Divergence in Lymphoid Tissue Apoptosis between Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infections of Nonhuman Primates , 2007, Journal of Virology.

[25]  P. Choyke,et al.  Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection , 2015, Nature Communications.

[26]  M. Nowak,et al.  The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection , 1997, Journal of virology.

[27]  R. Desrosiers,et al.  Animal models for acquired immunodeficiency syndrome. , 1987, Reviews of infectious diseases.

[28]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[29]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[30]  G. Trinchieri,et al.  Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.

[31]  A. Lackner,et al.  Visualizing Cytokine-Secreting Cells In Situ in the Rhesus Macaque Model of Chronic Gut Inflammation , 2005, Clinical Diagnostic Laboratory Immunology.

[32]  D. Weissman,et al.  The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation , 1996, The Journal of experimental medicine.

[33]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[34]  D. Douek,et al.  Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts , 2009, Nature Medicine.

[35]  K. Farrell,et al.  Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo. , 1993, Journal of clinical immunology.

[36]  Carole R. Baskin,et al.  Transcriptional Profiling in Pathogenic and Non-Pathogenic SIV Infections Reveals Significant Distinctions in Kinetics and Tissue Compartmentalization , 2009, PLoS pathogens.

[37]  J. Lifson,et al.  Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques. , 2015, The Journal of clinical investigation.

[38]  C. Apetrei,et al.  Where the Wild Things Are: Pathogenesis of SIV Infection in African Nonhuman Primate Hosts , 2010, Current HIV/AIDS reports.

[39]  S. Staprans,et al.  Simian Immunodeficiency Virus Replicates to High Levels in Naturally Infected African Green Monkeys without Inducing Immunologic or Neurologic Disease , 2001, Journal of Virology.

[40]  N. Liabakk,et al.  Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. , 1994, Blood.

[41]  Lesego Gabaitiri,et al.  Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. , 2013, AIDS research and human retroviruses.

[42]  R. Desrosiers,et al.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.

[43]  B. Haynes,et al.  Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection , 2010, PLoS pathogens.

[44]  L. Picker,et al.  Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis , 2009, The Journal of experimental medicine.

[45]  A S Perelson,et al.  Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.

[46]  Robert M. Grant,et al.  Simian Immunodeficiency Virus Disease Course Is Predicted by the Extent of Virus Replication during Primary Infection , 1999, Journal of Virology.